Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-11-11
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-30 (study day 50.0); relationship: POSSIBLE
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-14 (study day 96.0); relationship: POSSIBLE
Data queries
No data queries.